MTIF3
gene geneOn this page
Also known as IF-3mtIF3(mt)
Summary
MTIF3 (mitochondrial translational initiation factor 3, HGNC:29788) is a protein-coding gene on chromosome 13q12.2, encoding Translation initiation factor IF-3, mitochondrial (Q9H2K0). IF-3 binds to the 28S ribosomal subunit and shifts the equilibrium between 55S ribosomes and their 39S and 28S subunits in favor of the free subunits, thus enhancing the availability of 28S subunits on which protein synthesis initiation begins.
This gene encodes a translation initiation factor that is involved in mitochondrial protein synthesis. Polymorphism in this gene is associated with the onset of Parkinson’s disease. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 5.
Source: NCBI Gene 219402 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_152912
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29788 |
| Approved symbol | MTIF3 |
| Name | mitochondrial translational initiation factor 3 |
| Location | 13q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | IF-3mt, IF3(mt) |
| Ensembl gene | ENSG00000122033 |
| Ensembl biotype | protein_coding |
| OMIM | 619554 |
| Entrez | 219402 |
Gene structure
Transcript identifiers
Ensembl transcripts: 69 — 60 protein_coding, 9 protein_coding_CDS_not_defined
ENST00000381116, ENST00000381120, ENST00000405591, ENST00000460973, ENST00000461838, ENST00000464753, ENST00000471771, ENST00000483903, ENST00000484342, ENST00000485650, ENST00000485959, ENST00000493719, ENST00000884652, ENST00000884653, ENST00000884654, ENST00000884655, ENST00000884656, ENST00000884657, ENST00000884658, ENST00000884659, ENST00000884660, ENST00000884661, ENST00000884662, ENST00000920841, ENST00000920842, ENST00000920843, ENST00000920844, ENST00000920845, ENST00000920846, ENST00000920847, ENST00000920848, ENST00000920849, ENST00000920850, ENST00000920851, ENST00000966039, ENST00000966040, ENST00000966041, ENST00000966042, ENST00000966043, ENST00000966044, ENST00000966045, ENST00000966046, ENST00000966047, ENST00000966048, ENST00000966049, ENST00000966050, ENST00000966051, ENST00000966052, ENST00000966053, ENST00000966054, ENST00000966055, ENST00000966056, ENST00000966057, ENST00000966058, ENST00000966059, ENST00000966060, ENST00000966061, ENST00000966062, ENST00000966063, ENST00000966064, ENST00000966065, ENST00000966066, ENST00000966067, ENST00000966068, ENST00000966069, ENST00000966070, ENST00000966071, ENST00000966072, ENST00000966073
RefSeq mRNA: 4 — MANE Select: NM_152912
NM_001166261, NM_001166262, NM_001166263, NM_152912
CCDS: CCDS9322
Canonical transcript exons
ENST00000381120 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001487558 | 27450509 | 27450564 |
| ENSE00001487569 | 27435643 | 27435893 |
| ENSE00001487585 | 27445088 | 27445156 |
| ENSE00003664514 | 27439989 | 27440449 |
| ENSE00003672223 | 27437116 | 27437273 |
Expression profiles
Bgee: expression breadth ubiquitous, 255 present calls, max score 98.16.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 37.5682 / max 398.8763, expressed in 1805 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 136494 | 21.5985 | 1785 |
| 136491 | 14.8551 | 1776 |
| 136493 | 0.6970 | 379 |
| 136488 | 0.2601 | 122 |
| 136490 | 0.1035 | 32 |
| 136489 | 0.0541 | 22 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| apex of heart | UBERON:0002098 | 98.16 | gold quality |
| right atrium auricular region | UBERON:0006631 | 98.03 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.83 | gold quality |
| cardiac atrium | UBERON:0002081 | 97.78 | gold quality |
| cardiac ventricle | UBERON:0002082 | 97.74 | gold quality |
| right testis | UBERON:0004534 | 97.66 | gold quality |
| left testis | UBERON:0004533 | 97.61 | gold quality |
| body of pancreas | UBERON:0001150 | 97.37 | gold quality |
| heart | UBERON:0000948 | 97.36 | gold quality |
| calcaneal tendon | UBERON:0003701 | 97.20 | gold quality |
| testis | UBERON:0000473 | 97.06 | gold quality |
| rectum | UBERON:0001052 | 96.94 | gold quality |
| gastrocnemius | UBERON:0001388 | 96.94 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.94 | gold quality |
| muscle of leg | UBERON:0001383 | 96.89 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.86 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 96.83 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.81 | gold quality |
| gall bladder | UBERON:0002110 | 96.79 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 96.78 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.77 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.68 | gold quality |
| tendon | UBERON:0000043 | 96.63 | gold quality |
| left adrenal gland | UBERON:0001234 | 96.57 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 96.53 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 96.50 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 96.39 | gold quality |
| pancreas | UBERON:0001264 | 96.36 | gold quality |
| pituitary gland | UBERON:0000007 | 96.35 | gold quality |
| adrenal cortex | UBERON:0001235 | 96.33 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.56 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 7)
- the c.798C>T polymorphism of the MTIF3 gene showed allelic association with Parkinson’s disease (PMID:17267121)
- Changes in function or expression of MTIF3 indicates mitochondrial dysfunction and contributes to the risk of Parkinson’s disease. (PMID:20887776)
- genetic association studies in cohorts of prediabetic patients at multiple sites: Data suggest that an SNP in MTIF3 (rs1885988) is associated with greater weight loss following lifestyle intervention in overweight/obese subjects with prediabetes. (PMID:26253612)
- single nucleotide polymorphisms rs4771122 of MTIF3 was the variant most significantly associated with long-term weight loss after surgery. (PMID:26337695)
- This is dedicated to the mitochondrial translation initiation factor 3 (IF3mt), which plays a key role in the protein synthesis in mitochondria. Involvement of IF3mt in human health and disease is discussed. (PMID:31694510)
- Initiation Factor 3 is Dispensable For Mitochondrial Translation in Cultured Human Cells. (PMID:32346061)
- Identification of a weight loss-associated causal eQTL in MTIF3 and the effects of MTIF3 deficiency on human adipocyte function. (PMID:36876906)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mtif3 | ENSDARG00000039649 |
| mus_musculus | Mtif3 | ENSMUSG00000016510 |
| rattus_norvegicus | Mtif3 | ENSRNOG00000070811 |
Protein
Protein identifiers
Translation initiation factor IF-3, mitochondrial — Q9H2K0 (reviewed: Q9H2K0)
All UniProt accessions (1): Q9H2K0
UniProt curated annotations — full annotation on UniProt →
Function. IF-3 binds to the 28S ribosomal subunit and shifts the equilibrium between 55S ribosomes and their 39S and 28S subunits in favor of the free subunits, thus enhancing the availability of 28S subunits on which protein synthesis initiation begins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the IF-3 family.
RefSeq proteins (4): NP_001159733, NP_001159734, NP_001159735, NP_690876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001288 | Translation_initiation_fac_3 | Family |
| IPR019814 | Translation_initiation_fac_3_N | Domain |
| IPR036787 | T_IF-3_N_sf | Homologous_superfamily |
| IPR036788 | T_IF-3_C_sf | Homologous_superfamily |
Pfam: PF05198
UniProt features (21 total): strand 9, helix 5, turn 2, sequence variant 2, transit peptide 1, chain 1, region of interest 1
Structure
Experimental structures (PDB)
8 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 9HFM | ELECTRON MICROSCOPY | 3 |
| 8QRM | ELECTRON MICROSCOPY | 3.05 |
| 6RW5 | ELECTRON MICROSCOPY | 3.14 |
| 9HFN | ELECTRON MICROSCOPY | 3.3 |
| 6NEQ | ELECTRON MICROSCOPY | 3.32 |
| 6NF8 | ELECTRON MICROSCOPY | 3.48 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H2K0-F1 | 79.19 | 0.56 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
MSigDB gene sets: 84 (showing top):
GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATIONAL_INITIATION, GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY, GOBP_TRANSLATION, WANG_LMO4_TARGETS_DN, ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN, GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING, GOBP_ORGANELLE_DISASSEMBLY, NUYTTEN_EZH2_TARGETS_DN, GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING, GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING, GOMF_RIBOSOME_BINDING, GOBP_RIBOSOME_DISASSEMBLY, GOBP_MITOCHONDRIAL_GENE_EXPRESSION, ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN
GO Biological Process (4): ribosome disassembly (GO:0032790), mitochondrial translational initiation (GO:0070124), translation (GO:0006412), translational initiation (GO:0006413)
GO Molecular Function (5): translation initiation factor activity (GO:0003743), translation factor activity, RNA binding (GO:0008135), ribosome binding (GO:0043022), ribosomal small subunit binding (GO:0043024), protein binding (GO:0005515)
GO Cellular Component (1): mitochondrion (GO:0005739)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| translational initiation | 3 |
| translation | 2 |
| translation factor activity | 2 |
| organelle disassembly | 1 |
| mitochondrion | 1 |
| mitochondrial translation | 1 |
| peptidyltransferase activity | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| formation of translation initiation ternary complex | 1 |
| metabolic process | 1 |
| RNA binding | 1 |
| ribonucleoprotein complex binding | 1 |
| ribosome binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1232 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MTIF3 | MTIF2 | P46199 | 860 |
| MTIF3 | MTRF1L | Q9UGC7 | 678 |
| MTIF3 | GTF3A | Q92664 | 669 |
| MTIF3 | TMEM160 | Q9NX00 | 650 |
| MTIF3 | MRRF | Q96E11 | 636 |
| MTIF3 | MTRF1 | O75570 | 630 |
| MTIF3 | TACO1 | Q9BSH4 | 619 |
| MTIF3 | GFM2 | Q969S9 | 619 |
| MTIF3 | ATP5IF1 | Q9UII2 | 614 |
| MTIF3 | QPCTL | Q9NXS2 | 603 |
| MTIF3 | TNNI3K | Q59H18 | 596 |
| MTIF3 | V9GXZ4 | V9GXZ4 | 596 |
| MTIF3 | ZNF608 | Q9ULD9 | 594 |
| MTIF3 | LINGO2 | Q7L985 | 584 |
| MTIF3 | SEC16B | Q96JE7 | 583 |
| MTIF3 | NUDT3 | O95989 | 583 |
IntAct
246 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SIAH1 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTIF3 | SIAH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NAT8 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STRIT1 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLP1 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UNC50 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ITGB2 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BMP10 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CD47 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LHFPL5 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOK | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF202 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYBC1 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM254 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZDHHC15 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SERTM1 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PLN | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM128 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM218 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CXCL9 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CDIPT | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CABP7 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM42 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMED8 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| APOD | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MGST3 | MTIF3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (296): MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Biochemical Activity), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid), MTIF3 (Two-hybrid)
ESM2 similar proteins: A0JMA8, A4IHS0, B5DF07, D3ZRC4, D6WMX4, E7EXT2, F7AEX0, F7BJB9, O15091, O93530, Q09287, Q14149, Q1L987, Q24558, Q28C44, Q2KI45, Q2TBE0, Q32NQ8, Q3MHI8, Q3UFY8, Q4KLI2, Q4R366, Q5RDI0, Q5U245, Q5U2R4, Q5VZ89, Q5XTS1, Q66JD1, Q66JJ4, Q6DDV1, Q6GLI9, Q7JUX9, Q7L0Y3, Q7Z401, Q86VD1, Q8C1Z8, Q8JZY4, Q8K1N1, Q8N6Q8, Q8TBZ6
Diamond homologs: A2C586, Q32KZ1, Q3B0M2, Q46IH3, Q9CZD5, Q9H2K0, Q5NL80, Q8XJ67
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
960 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 13:27437279:T:C | acceptor_gain | 1.0000 |
| 13:27437279:T:TC | acceptor_gain | 1.0000 |
| 13:27445154:CAG:C | acceptor_gain | 1.0000 |
| 13:27445157:C:CC | acceptor_gain | 1.0000 |
| 13:27435890:CCTC:C | acceptor_gain | 0.9900 |
| 13:27435891:CTCC:C | acceptor_gain | 0.9900 |
| 13:27435892:TCC:T | acceptor_loss | 0.9900 |
| 13:27435892:TCCT:T | acceptor_gain | 0.9900 |
| 13:27435893:CCTAA:C | acceptor_loss | 0.9900 |
| 13:27435894:C:CA | acceptor_loss | 0.9900 |
| 13:27435894:C:CC | acceptor_gain | 0.9900 |
| 13:27437110:ACTT:A | donor_loss | 0.9900 |
| 13:27437111:CTTA:C | donor_loss | 0.9900 |
| 13:27437112:TTAC:T | donor_loss | 0.9900 |
| 13:27437114:A:C | donor_loss | 0.9900 |
| 13:27437115:C:CG | donor_loss | 0.9900 |
| 13:27437274:C:CC | acceptor_gain | 0.9900 |
| 13:27445082:TCCTA:T | donor_loss | 0.9900 |
| 13:27445083:CCTA:C | donor_loss | 0.9900 |
| 13:27445084:CTACC:C | donor_loss | 0.9900 |
| 13:27445085:TA:T | donor_loss | 0.9900 |
| 13:27445086:A:T | donor_loss | 0.9900 |
| 13:27445087:C:CA | donor_loss | 0.9900 |
| 13:27445152:GACAG:G | acceptor_gain | 0.9900 |
| 13:27445160:A:C | acceptor_gain | 0.9900 |
| 13:27445165:C:CT | acceptor_gain | 0.9900 |
| 13:27449749:A:AC | donor_gain | 0.9900 |
| 13:27449750:T:C | donor_gain | 0.9900 |
| 13:27435891:CTC:C | acceptor_gain | 0.9800 |
| 13:27437271:GTCCT:G | acceptor_loss | 0.9800 |
AlphaMissense
1841 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:27437168:A:T | V189D | 0.987 |
| 13:27437209:C:A | K175N | 0.983 |
| 13:27437209:C:G | K175N | 0.983 |
| 13:27440099:A:T | V117D | 0.976 |
| 13:27437190:A:G | W182R | 0.974 |
| 13:27437190:A:T | W182R | 0.974 |
| 13:27437257:C:A | K159N | 0.972 |
| 13:27437257:C:G | K159N | 0.972 |
| 13:27440063:T:G | Q129P | 0.972 |
| 13:27440108:A:G | L114P | 0.968 |
| 13:27440102:A:T | L116Q | 0.967 |
| 13:27437188:C:A | W182C | 0.966 |
| 13:27437188:C:G | W182C | 0.966 |
| 13:27440067:A:C | Y128D | 0.964 |
| 13:27440060:A:T | L130H | 0.963 |
| 13:27435850:G:T | A221D | 0.961 |
| 13:27437162:A:C | I191S | 0.958 |
| 13:27440135:A:T | V105E | 0.958 |
| 13:27437162:A:G | I191T | 0.951 |
| 13:27435800:A:G | C238R | 0.949 |
| 13:27440060:A:G | L130P | 0.949 |
| 13:27437221:A:C | D171E | 0.948 |
| 13:27437221:A:T | D171E | 0.948 |
| 13:27440066:T:G | Y128S | 0.947 |
| 13:27440126:A:G | L108P | 0.947 |
| 13:27437222:T:C | D171G | 0.946 |
| 13:27437252:A:G | L161P | 0.946 |
| 13:27440183:A:G | L89S | 0.946 |
| 13:27440105:C:G | R115P | 0.945 |
| 13:27440030:C:G | R140P | 0.944 |
dbSNP variants (sampled 300 via entrez): RS1000056002 (13:27447810 A>C,G), RS1000208911 (13:27442115 G>A,T), RS1000284566 (13:27452378 T>C), RS1000311151 (13:27436687 A>G,T), RS1000348610 (13:27451739 C>G,T), RS1000365430 (13:27436833 G>C), RS1000452425 (13:27451536 C>T), RS1000517173 (13:27440526 G>C,T), RS1000543056 (13:27441869 G>A), RS1000646836 (13:27437716 T>C), RS1000795406 (13:27440806 C>A,T), RS1001329111 (13:27442446 G>C), RS1001382445 (13:27442686 C>G), RS1001625057 (13:27447911 G>A,C,T), RS1001627662 (13:27445138 C>T)
Disease associations
OMIM: gene MIM:619554 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000830_34 | Body mass index | 9.000000e-10 |
| GCST002783_14 | Body mass index | 2.000000e-07 |
| GCST002783_459 | Body mass index | 9.000000e-11 |
| GCST002783_494 | Body mass index | 2.000000e-10 |
| GCST003542_166 | Night sleep phenotypes | 5.000000e-06 |
| GCST004495_55 | BMI (adjusted for smoking behaviour) | 8.000000e-07 |
| GCST004497_12 | Body mass index (joint analysis main effects and smoking interaction) | 2.000000e-07 |
| GCST004679_4 | Psychosis proneness (hypomanic personality scale and perceptual aberration scale) | 7.000000e-07 |
| GCST004904_169 | Body mass index | 2.000000e-10 |
| GCST007647_6 | Estimated glomerular filtration rate change in renal transplantation (recipient effect) | 1.000000e-06 |
| GCST010988_462 | Adult body size | 8.000000e-13 |
| GCST012282_8 | BMI x environmental factors (excluding physical activity) interaction | 3.000000e-06 |
| GCST012283_5 | BMI x environmental factors (including physical activity) interaction | 4.000000e-06 |
EFO canonical traits (11, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004318 | smoking behavior |
| EFO:0008337 | psychosis predisposition measurement |
| EFO:0005199 | renal transplant outcome measurement |
| EFO:0006527 | smoking status measurement |
| EFO:0009374 | energy intake measurement |
| EFO:0009695 | household income |
| EFO:0010810 | protein intake measurement |
| EFO:0010811 | carbohydrate intake measurement |
| EFO:0011015 | educational attainment |
| EFO:0008002 | physical activity measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cisplatin | affects expression, affects cotreatment, increases expression | 2 |
| dicrotophos | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| isobutyl alcohol | affects cotreatment, decreases expression, increases abundance | 1 |
| beta-methylcholine | affects expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Gasoline | decreases expression, increases abundance, affects cotreatment | 1 |
| Hydrogen Peroxide | affects cotreatment, decreases expression | 1 |
| Lead | affects splicing | 1 |
| Methotrexate | increases expression | 1 |
| Polycyclic Aromatic Hydrocarbons | affects cotreatment, decreases expression, increases abundance | 1 |
| Quercetin | decreases expression | 1 |
| Theophylline | affects cotreatment, decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Josamycin | decreases response to substance | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | affects cotreatment, decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.